Clinical Trial Update: Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pralatrexate with vitamin B12 and folic acid for previously treated recurrent or metastatic head and neck squamous cell carcinoma; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Pralatrexate (pralatrexate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-11-20